3.29
price up icon1.86%   0.06
after-market 시간 외 거래: 3.30 0.010 +0.30%
loading
전일 마감가:
$3.23
열려 있는:
$3.53
하루 거래량:
159.29K
Relative Volume:
0.63
시가총액:
$24.92M
수익:
-
순이익/손실:
$-72.26M
주가수익비율:
-1.5971
EPS:
-2.06
순현금흐름:
$-68.44M
1주 성능:
-9.86%
1개월 성능:
-39.63%
6개월 성능:
+171.90%
1년 성능:
+171.90%
1일 변동 폭
Value
$3.0101
$3.8707
1주일 범위
Value
$3.0101
$3.915
52주 변동 폭
Value
$3.0101
$10.84

레인 테라퓨틱스 Stock (RAIN) Company Profile

Name
명칭
Rain Enhancement Technologies Holdco Inc
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-03-07
Name
최신 SEC 제출 서류
Name
RAIN's Discussions on Twitter

RAIN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RAIN
Rain Enhancement Technologies Holdco Inc
3.29 24.92M 0 -72.26M -68.44M -2.06
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.22 117.23B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
665.46 72.75B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
636.02 38.65B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.99 34.69B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.50 27.45B 3.30B -501.07M 1.03B -2.1146

레인 테라퓨틱스 Stock (RAIN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-03-21 개시 SVB Securities Outperform
2023-01-31 재개 ROTH Capital Buy
2023-01-23 개시 Mizuho Buy
2022-09-12 개시 H.C. Wainwright Buy
2022-04-01 개시 Oppenheimer Outperform
2021-09-14 재개 Goldman Neutral
2021-07-20 개시 Piper Sandler Overweight
2021-05-18 개시 Citigroup Buy
2021-05-18 개시 Goldman Buy
2021-05-18 개시 Guggenheim Buy
2021-05-18 개시 Piper Sandler Overweight
모두보기

레인 테라퓨틱스 주식(RAIN)의 최신 뉴스

pulisher
Feb 11, 2025

Rain enhancement technologies' Paul Dacier buys $150,040 in stock - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 11, 2025
pulisher
Feb 11, 2025

Rain enhancement technologies' Paul Dacier buys $150,040 in stock By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 10, 2025

Rain enhancement technologies’ Paul Dacier buys $150,040 in stock By Investing.com - Investing.com Nigeria

Feb 10, 2025
pulisher
Feb 04, 2025

Rain Enhancement Technologies names new CEO to drive growth - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

Rain Enhancement Technologies Appoints Randall Seidl as Sole CEO -February 03, 2025 at 01:24 pm EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer - Business Wire

Feb 03, 2025
pulisher
Jan 27, 2025

Personal Finance - Business Wire

Jan 27, 2025
pulisher
Jan 15, 2025

UKG and Dell Technologies Launch Solar Community Hub in Mexico in Collaboration With Tecnológico de Monterrey and Computer Aid International - Quantisnow

Jan 15, 2025
pulisher
Jan 06, 2025

Dell transforms AI PC portfolio for anywhere productivity - Quantisnow

Jan 06, 2025
pulisher
Jan 06, 2025

Stock market today: NextNav -22.28%, Intrusion -19.76% among biggest losers in early trading - Business Upturn

Jan 06, 2025
pulisher
Jan 06, 2025

Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn

Jan 06, 2025
pulisher
Jan 03, 2025

Bad weather alert for Sabah, Sarawak and Labuan - The Malaysian Reserve

Jan 03, 2025
pulisher
Jan 03, 2025

Stock market news: Dogness (International) -25.96%, Heartcore Enterprises -21.48% among biggest losers during mid day trading - Business Upturn

Jan 03, 2025
pulisher
Jan 03, 2025

FTSE 100 Holds Steady as Energy Shares Offset Sectoral Declines – Market - HPBL

Jan 03, 2025
pulisher
Jan 03, 2025

FTSE 100 Pauses After Weekly Surge Amid Energy Gains and Retail Challenges – Market - HPBL

Jan 03, 2025
pulisher
Jan 03, 2025

FTSE 100 Rallies While NASDAQ 100 Wavers: A Tale of Two Indices – Market - HPBL

Jan 03, 2025
pulisher
Jan 03, 2025

DAX Begins 2025 Strong: Can It Break the 20,523 Record High? – Market - HPBL

Jan 03, 2025
pulisher
Jan 02, 2025

Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. But Geopolitical Uncertainty Could Slow M&A Growth in 2025 - Law.com International

Jan 02, 2025
pulisher
Jan 02, 2025

Deal Watch: Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. Plus, Mixed Messages for 2025 M&A - Law.com

Jan 02, 2025
pulisher
Jan 02, 2025

Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn

Jan 02, 2025
pulisher
Jan 02, 2025

Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn

Jan 02, 2025
pulisher
Jan 02, 2025

Spain IBEX 35 Rises on Energy and Consumer Goods Gains, Gold and Oil Prices Surge – Market - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Fidelity MSCI Financials Index ETF (FNCL): A Cost-Effective Gateway to the Financial Sector – Market - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Fidelity Boosts Valuation of Elon Musk X by 32%, Signaling Renewed Optimism – Market - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

JPMorgan Global Growth & Income Plc Issues 200,000 Shares, Raising Capital for Future Strategy - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Rain Oncology, Alset Inc., and Other Stocks Surge as Investors Eye Market Opportunities - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Tech Stocks Display Mixed Performance in Early Market Trading: Tesla Drops While MicroStrategy Soars - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Trump Media & Technology Group (DJT) Sees Modest Stock Rise Amid Volatility – Market - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

3 Vanguard ETF to Buy in 2025 for Higher Yields and Lower P/E Ratios Amid Market Volatility - HPBL

Jan 02, 2025
pulisher
Jan 02, 2025

Stock market today: Neumora Therapeutics down by 81.14% while Rain Oncology surged by 676.86% in early trading - Business Upturn

Jan 02, 2025
pulisher
Jan 02, 2025

Stock market today: Rain Oncology +603.31%, Alset +103.93% among top gainers in early trading - Business Upturn

Jan 02, 2025
pulisher
Jan 02, 2025

Rain Enhancement Technologies Completes Business Combination with Coliseum Acquisition - Defense World

Jan 02, 2025

레인 테라퓨틱스 (RAIN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
자본화:     |  볼륨(24시간):